Viewing Study NCT01439061


Ignite Creation Date: 2025-12-24 @ 12:23 PM
Ignite Modification Date: 2026-06-02 @ 6:47 PM
Study NCT ID: NCT01439061
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2011-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Growth disorders View
None Saizen View
None Easypod View
None Growth hormone View
None Pediatric subject View